Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus

Cross-national health care database utilization between Spain and France: results from the EPICHRONIC study assessing the prevalence of type 2 diabetes mellitus

Guillaume Moulis,1–3,* Berta Ibañez,4–6,* Aurore Palmaro,2,3 Felipe Aizpuru,6–8 Eduardo Millan,6,8 Maryse Lapeyre-Mestre,2,3,9 Laurent Sailler,1–3 Koldo Cambra5,6,10 1Department of Internal Medicine, Toulouse University Hospital, Toulouse, France; 2...

Full description

Bibliographic Details
Main Authors:	Moulis G, Ibañez B, Palmaro A, Aizpuru F, Millan E, Lapeyre-Mestre M, Sailler L, Cambra K
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-07-01
Series:	Clinical Epidemiology
Subjects:	epidemiology pharmacoepidemiology electronic healthcare database cross-national study population-based study type 2 diabetes mellitus.
Online Access:	https://www.dovepress.com/cross-national-health-care-database-utilization-between-spain-and-fran-peer-reviewed-article-CLEP

Similar Items

Immeasurable Time Bias in Self-controlled Designs: Case-crossover, Case-time-control, and Case-case-time-control Analyses
by: Han Eol Jeong, et al.
Published: (2023-02-01)

Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review
by: Nathalie Gault, et al.
Published: (2017-02-01)

Corticosteroid Risk Function of Severe Infection in Primary Immune Thrombocytopenia Adults. A Nationwide Nested Case-Control Study.
by: Guillaume Moulis, et al.
Published: (2015-01-01)

Development and Validation of Case-Finding Algorithms for Digestive Cancer in the Spanish Healthcare Database BIFAP
by: Encarnación Fernández-Antón, et al.
Published: (2024-01-01)

Characteristics of hospital differences in missing of clinical laboratory test results in a multi-hospital observational database contributing to MID-NET® in Japan
by: Maki Komamine, et al.
Published: (2021-06-01)

Antidepressants Drug Use during COVID-19 Waves in the Tuscan General Population: An Interrupted Time-Series Analysis
by: Ippazio Cosimo Antonazzo, et al.
Published: (2022-01-01)

Vaccination during the First Diagnosis of Multiple Myeloma: A Cohort Study of the French National Health Insurance Database
by: Guilhem Tournaire, et al.
Published: (2020-12-01)

Iron salt supplementation during gestation and gestational diabetes mellitus
by: Vanessa Iribarrem Avena Miranda, et al.
Published: (2023-10-01)

Risk factors and drugs that trigger the onset of Stevens–Johnson syndrome and toxic epidermal necrolysis: A population-based cohort study using the Shizuoka Kokuho databaseCapsule Summary
by: Nanako Ubukata, MS, et al.
Published: (2023-06-01)

Psychiatric Adverse Events Associated With Infliximab: A Cohort Study From the French Nationwide Discharge Abstract Database
by: Eve-Marie Thillard, et al.
Published: (2020-04-01)

Thiazolidinedione Use Is Associated with a Borderline Lower Risk of Multiple Myeloma and a Significantly Lower Risk of Death in Patients with Type 2 Diabetes Mellitus in Taiwan
by: Chin-Hsiao Tseng
Published: (2023-08-01)

PHARMACOEPIDEMIOLOGY: FROM THEORY TO PRACTICE
by: S. A. Rachina, et al.
Published: (2015-03-01)

A systematic assessment of the association between frequently prescribed medicines and the risk of common cancers: a series of nested case-control studies
by: R. D. McDowell, et al.
Published: (2021-01-01)

Prevalence and Age Structure of Polypharmacy in Poland: Results of the Analysis of the National Real-World Database of 38 Million Citizens
by: Przemysław Kardas, et al.
Published: (2021-04-01)

Dealing with missing data in laboratory test results used as a baseline covariate: results of multi-hospital cohort studies utilizing a database system contributing to MID-NET® in Japan
by: Maki Komamine, et al.
Published: (2023-10-01)

A real-world study on unmet medical needs in triptan-treated migraine: prevalence, preventive therapies and triptan use modification from a large Italian population along two years
by: Carlo Piccinni, et al.
Published: (2019-06-01)

Oncology Drug Effectiveness from Electronic Health Record Data Calibrated Against RCT Evidence: The PARSIFAL Trial Emulation
by: Merola D, et al.
Published: (2022-10-01)

Data transparency for building a stronger healthcare system: A case study from Argentinean administrative drug utilization data sources
by: Martín Cañás, et al.
Published: (2021-05-01)

Utilization study of antidiabetic agents in a teaching hospital of Sikkim and adherence to current standard treatment guidelines
by: Sushrut Varun Satpathy, et al.
Published: (2016-01-01)

Pharmacoepidemiology – Assessing the Risks and Benefits of Drugs in the Postmarketing Phase
by: Christoph R. Meier
Published: (2006-02-01)

DRUG-INDUCED REACTIONS IN STOMATOLOGY
by: Cristina-Maria Gavrilescu, et al.
Published: (2015-01-01)

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study
by: Louis Létinier, et al.
Published: (2019-03-01)

Diuretic drug utilization in neonates: a French prescription database analysis
by: Silvia Iacobelli, et al.
Published: (2024-03-01)

Statin treatment is not associated with an increased risk of adrenal insufficiency in real-world setting
by: Sandy Maumus-Robert, et al.
Published: (2023-09-01)

Pharmacoepidemiology /
by: Strom, Brian L.
Published: (2005)

Agreement between different recall periods in drug utilization studies
by: Cassia Garcia Moraes, et al.

Effectiveness and safety of direct oral anticoagulants with antiplatelet agents in patients with venous thromboembolism: A multi‐database cohort study
by: Antonios Douros, et al.
Published: (2022-01-01)

Antiresorptive Drugs and the Risk of Femoral Shaft Fracture in Men and Women With Osteoporosis: A Cohort Study Using the National Database of Health Insurance Claims of Japan
by: Takumi Imai, et al.
Published: (2023-12-01)

Bias in pharmacoepidemiologic studies using secondary health care databases: a scoping review
by: Guillermo Prada-Ramallal, et al.
Published: (2019-03-01)

Medication utilization in traumatic brain injury patients—insights from a population-based matched cohort study
by: Yasmina Molero, et al.
Published: (2024-02-01)

The Risk of Multiple Myeloma Is Reduced in Metformin Initiators: A Retrospective Cohort Study in Taiwanese Patients with Type 2 Diabetes Mellitus
by: Chin-Hsiao Tseng
Published: (2022-11-01)

Development and evaluation of an algorithm to link mothers and infants in two US commercial healthcare claims databases for pharmacoepidemiology research
by: James Weaver, et al.
Published: (2023-10-01)

Data Sources for Drug Utilization Research in Brazil—DUR-BRA Study
by: Lisiane Freitas Leal, et al.
Published: (2022-01-01)

Psychoactive drugs in the Brazilian public health system: Use profile and associated factors
by: Manuela Roque Siani-Morello, et al.
Published: (2022-07-01)

Agreement between PRE2DUP register data modeling method and comprehensive drug use interview among older persons
by: Taipale H, et al.
Published: (2016-10-01)

The pattern of medication usage in the southern region of Iran: A population-based pharmacoepidemiological study
by: Marziyeh Zare, et al.
Published: (2021-01-01)

Utilization of Drugs with Pharmacogenetic Dosing Recommendations in Switzerland: A Descriptive Study Using the Helsana Database
by: Wittwer NL, et al.
Published: (2022-11-01)

Use of National Database of Health Insurance Claims and Specific Health Checkups for examining practical utilization and safety signal of a drug to support regulatory assessment on postmarketing drug safety in Japan
by: Haruka Shida, et al.
Published: (2023-02-01)

Approaches to Assessing the Quality of Observational Studies of Clinical Practice Based on the Big Data Analysis
by: S. R. Gilyarevsky
Published: (2021-09-01)

Association between statin use and the risk for idiopathic pulmonary fibrosis and its prognosis: a nationwide, population-based study
by: Jimyung Park, et al.
Published: (2024-04-01)